A detailed history of Simplex Trading, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,800 shares of FLGT stock, worth $38,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,800
Previous 4,246 57.61%
Holding current value
$38,088
Previous $92,000 61.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$19.09 - $22.57 $46,694 - $55,206
-2,446 Reduced 57.61%
1,800 $35,000
Q1 2024

Apr 25, 2024

BUY
$21.55 - $29.29 $38,337 - $52,106
1,779 Added 72.11%
4,246 $92,000
Q4 2023

Feb 02, 2024

BUY
$23.64 - $30.27 $58,319 - $74,676
2,467 New
2,467 $71,000
Q2 2023

Aug 04, 2023

BUY
$28.52 - $40.7 $243,304 - $347,211
8,531 Added 346.09%
10,996 $407,000
Q1 2023

Apr 27, 2023

BUY
$29.39 - $36.27 $72,446 - $89,405
2,465 New
2,465 $76,000
Q3 2022

Nov 04, 2022

BUY
$37.92 - $63.74 $202,341 - $340,116
5,336 New
5,336 $203,000
Q1 2022

May 02, 2022

SELL
$49.85 - $96.11 $92,970 - $179,245
-1,865 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$77.3 - $105.0 $22,417 - $30,450
290 Added 18.41%
1,865 $187,000
Q3 2021

Oct 28, 2021

SELL
$74.87 - $110.87 $14,974 - $22,174
-200 Reduced 11.27%
1,575 $137,000
Q2 2021

Aug 12, 2021

BUY
$66.8 - $100.45 $118,570 - $178,298
1,775 New
1,775 $163,000
Q1 2021

Apr 26, 2021

SELL
$59.3 - $183.85 $1.24 Million - $3.85 Million
-20,949 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$31.01 - $52.1 $626,339 - $1.05 Million
20,198 Added 2689.48%
20,949 $1.09 Million
Q3 2020

Oct 14, 2020

BUY
$15.89 - $50.51 $11,933 - $37,933
751 New
751 $30,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $640M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.